Acetrizoic Acid | CAS#85-36-9 | contrast medium

Acetrizoic Acid
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 561600

CAS#: 85-36-9

Description: Acetrizoic Acid is a high-osmolality, iodine-based radiographic contrast medium.

Chemical Structure

Acetrizoic Acid

CAS# 85-36-9

Instruction

Theoretical Analysis

MedKoo Cat#: 561600
Name: Acetrizoic Acid
CAS#: 85-36-9
Chemical Formula: C9H6I3NO3
Exact Mass: 556.75
Molecular Weight: 556.860
Elemental Analysis: C, 19.41; H, 1.09; I, 68.37; N, 2.52; O, 8.62

Price and Availability

Size	Price	Availability	Quantity
1g	USD 230
5g	USD 470
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: Acetrizoic Acid; Opacaron; Urokon;

IUPAC/Chemical Name: 3-Acetamido-2,4,6-triiodobenzoic acid

InChi Key: GNOGSFBXBWBTIG-UHFFFAOYSA-N

InChi Code: InChI=1S/C9H6I3NO3/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16/h2H,1H3,(H,13,14)(H,15,16)

SMILES Code: O=C(O)C1=C(I)C=C(I)C(NC(C)=O)=C1I

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Instruction:

View handling instruction

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 556.86 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: The MICAD Research Team. N-(2,3-Dihydroxypropyl)-N´-(2-hydroxyethyl)-5-[N-(2,3-dihydroxypropyl)acetamido]- 2,4,6-triiodoisophthalamide. 2006 Jul 12 [updated 2006 Aug 9]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26369/ PubMed PMID: 20641973.

2: Cheng KT. N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl-3-methoxypropyl)-acetamidol]-2 ,4,6-triiodoisophthalamide. 2006 Mar 6 [updated 2008 Mar 4]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26367/ PubMed PMID: 20641971.

3: Cheng KT. N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodois ophthalamide. 2006 Feb 7 [updated 2008 Feb 7]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26366/ PubMed PMID: 20641970.

4: Cheng KT. 5-[3-Hydroxy-2-hydroxymethyl-propionamido)-N,N´-dimethyl-N,N´-bis-(2,3-dihydroxyp ropyl)-2,4,6-triiodoisophthalamide. 2006 May 16 [updated 2008 Apr 21]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK25584/ PubMed PMID: 20641966.

5: Sergeev PV, Sviridov NK. [Effect of contrast media on the cardiovascular system (review of the literature)]. Farmakol Toksikol. 1977 Jul-Aug;40(4):498-503. Review. Russian. PubMed PMID: 332518.

6: Classen JN, Martin RE, Thompson NO. Complications of colon and rectum following diagnosis. Prophylaxis and therapy. Acta Chir Belg. 1977 May-Jun;76(3):235-47. Review. PubMed PMID: 331814.

7: Lazecki L. [Nephrotropic contrast media]. Pol Przegl Radiol Med Nukl. 1975 Mar-Apr;39(2):239-50. Review. Polish. PubMed PMID: 1096096.

8: Saxton HM. Review article: urography. Br J Radiol. 1969 May;42(497):321-46. Review. PubMed PMID: 4914357.

Your view history

Acetrizoic Acid featured